|
Variables
|
Immune-virological failure discordant
|
COR(95%CI)
|
AOR(95%CI)
|
P value
|
|---|
|
Yes
|
No
|
|---|
|
Age
|
18–29
|
10 (52.6%)
|
9 (47.4%)
|
0.27(0.04–1.66)
|
2.46 (0.104–0.04)
|
0.577
|
|
30–39
|
22 (71.0%)
|
9 (29.0%)
|
0.61(0.10–3.45)
|
8.29 (0.38–179.94)
|
0.178
|
|
40–49
|
14 (53.8%)
|
12 (46.2%)
|
0.29(0.05–1.64)
|
6.51 (0.27–154.25)
|
0.246
|
|
> = 50
|
8(80.0%)
|
2 (20.0%)
| | |
Ref
|
|
Duration of ART in yrs.
|
<=6
|
20 (51.3%)
|
19 (48.7%)
|
2.48(1.01–6.09)
|
5.68 (0.569–56.71)
|
0.139
|
|
> 6
|
34 (72.3%)
|
13(27.7%)
| | |
Ref
|
|
Reason of switching drug
|
Toxicity
|
15 (83.3%)
|
3 (16.7%)
|
11(2.15–56.09)
|
11(2.15–56.09)
|
0.004*
|
|
Others
|
5 (31.2%)
|
11 (68.8%)
| | |
Ref
|
- Note: * Has significant association
- Those variables with in p value < 0.2 under bivariate analysis were included with in multivariate analysis
- COR crude odds ratio, AOR adjusted odds ratio, Ref reference, CI confidence interval, p significant value
